Cargando…

Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act

Detalles Bibliográficos
Autores principales:	Snow, Timothy Arthur Chandos, Cesar, Antonio, Singer, Mervyn, Arulkumaran, Nishkantha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354275/ https://www.ncbi.nlm.nih.gov/pubmed/35932059 http://dx.doi.org/10.1186/s13054-022-04104-y

Ejemplares similares

“L'histoire se répète”, one size does not fit all. Author’s reply
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2021)

Immunomodulators in COVID-19: Two Sides to Every Coin
por: Snow, Timothy A. C., et al.
Publicado: (2020)

Beneficial ex vivo immunomodulatory and clinical effects of clarithromycin in COVID-19
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2022)

Steroids in ARDS: more light is being shed
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020)

COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study
por: Longobardo, Alessia, et al.
Publicado: (2021)

Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2021)

Use of non-invasive ventilation for patients with COVID-19: a cause for concern?
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020)

Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome
por: Longobardo, Alessia, et al.
Publicado: (2021)

Creating complex protocells and prototissues using simple DNA building blocks
por: Arulkumaran, Nishkantha, et al.
Publicado: (2023)

Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression
por: Snow, Timothy A.C., et al.
Publicado: (2021)

Sex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort
por: Arulkumaran, Nishkantha, et al.
Publicado: (2021)

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022)

Association Between Hypocholesterolemia and Mortality in Critically Ill Patients With Sepsis: A Systematic Review and Meta-Analysis
por: Hofmaenner, Daniel A., et al.
Publicado: (2023)

Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort
por: Arulkumaran, Nishkantha, et al.
Publicado: (2021)

Is the inflammasome a potential therapeutic target in renal disease?
por: Turner, Clare M, et al.
Publicado: (2014)

Fever in Sepsis: Still a Hot Topic
por: Leijte, Guus Pieter, et al.
Publicado: (2019)

Sequential Analysis of a Panel of Biomarkers and Pathologic Findings in a Resuscitated Rat Model of Sepsis and Recovery
por: Arulkumaran, Nishkantha, et al.
Publicado: (2017)

Adult-onset Still's disease associated with collapsing glomerulopathy
por: Arulkumaran, Nishkantha, et al.
Publicado: (2010)

P2X(7) receptor antagonism ameliorates renal dysfunction in a rat model of sepsis
por: Arulkumaran, Nishkantha, et al.
Publicado: (2018)

Sepsis in severe COVID-19 is rarely septic shock: a retrospective single-centre cohort study
por: Arina, Pietro, et al.
Publicado: (2021)

Purinergic signaling in inflammatory renal disease
por: Arulkumaran, Nishkantha, et al.
Publicado: (2013)

The Pharmacology and Therapeutic Utility of Sodium Hydroselenide
por: Samra, Kavitej, et al.
Publicado: (2021)

Reply to Leijte et al.: Fever in Sepsis: Still a Hot Topic
por: Bhavani, Sivasubramanium V., et al.
Publicado: (2019)

Butyrate Supplementation Exacerbates Myocardial and Immune Cell Mitochondrial Dysfunction in a Rat Model of Faecal Peritonitis
por: Peters, Vera B. M., et al.
Publicado: (2022)

Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease.
por: Pukhalsky, Alexander L, et al.
Publicado: (2004)

Immunomodulators: still having a role?
por: Venner, Jeffery M, et al.
Publicado: (2022)

Clarithromycin reverses sepsis-induced immunoparalysis of monocytes
por: Raftogiannis, M, et al.
Publicado: (2009)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Response letter to “Latent class analysis of 216 patients with adult-onset Still’s disease” by Sugiyama et al.
por: Delplanque, Marion, et al.
Publicado: (2022)

Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2006)

The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply
por: Hofmaenner, Daniel A., et al.
Publicado: (2022)

Biomarkers in sepsis
por: Singer, Mervyn
Publicado: (2013)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Renal Tubular Cell Mitochondrial Dysfunction Occurs Despite Preserved Renal Oxygen Delivery in Experimental Septic Acute Kidney Injury
por: Arulkumaran, Nishkantha, et al.
Publicado: (2018)

Phase III Trial of Albumin in Malaria Still Lacks Scientific Justification
por: Woodrow, Charles J, et al.
Publicado: (2007)

Sepsis: personalization v protocolization?
por: Singer, Mervyn
Publicado: (2019)

Reply to Tasker and to Lellouche and L’Her
por: Palmer, Edward, et al.
Publicado: (2020)

0035. Mitochondrial uncoupling contributes to fever in sepsis
por: Greco, E, et al.
Publicado: (2014)

Biomarkers for sepsis – past, present and future
por: Singer, Mervyn
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p5kbv7shk7j5a9bhtjiareectq